Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an essential electrolyte used to treat and prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment of hypokalemia (serum potassium < 3.5 mEq/L). * Prevention of hypokalemia in patients at risk. ## Adult Dosing * **Oral:** Doses vary widely based on severity of hypokalemia and clinical scenario. * **Mild to moderate hypokalemia (3.0-3.4 mEq/L):** 20-40 mEq daily in 1-2 divided doses. * **Severe hypokalemia (< 3.0 mEq/L):** May require higher doses, often 60-100 mEq daily or more, carefully monitored. * Maximum oral dose: Generally not to exceed 20 mEq per dose or 100 mEq per day without close cardiac monitoring. Extended-release formulations are typically dosed once or twice daily. * **Intravenous (IV):** Dosing is highly individualized and depends on serum potassium levels and patient condition. Must be administered via infusion pump. * **Mild to moderate hypokalemia:** 20-40 mEq in 1 L of IV fluid over 2-6 hours. * **Severe hypokalemia:** May require higher doses (e.g., up to 60-80 mEq) in 1 L of IV fluid infused over 3-6 hours. * **Emergency/Life-threatening hypokalemia:** Doses up to 10 mEq/hour may be given, often in a central line. Higher rates may be necessary in extreme emergencies but carry significant risk. * Maximum IV dose: Not to exceed 20 mEq per hour unless in a life-threatening situation with continuous cardiac monitoring. Total daily dose typically does not exceed 200 mEq. ## Pediatric Dosing * Dosing is weight-based and dependent on serum potassium levels. Local protocol is critical. * **Oral:** Typically 1-2 mEq/kg/day in divided doses, not to exceed adult maximums. Maximum single dose usually 10-20 mEq. * **Intravenous (IV):** * **Maintenance:** 20-40 mEq per liter of IV fluid. * **Correction:** 0.3-0.5 mEq/kg per dose administered over 1-3 hours, not to exceed 1 mEq/kg/hour or 10 mEq per dose, with ECG monitoring. Higher doses may be used in severe cases under strict monitoring. ## Dose Adjustments * **Renal Impairment:** Dose reduction is essential. Monitor potassium closely. Avoid in severe renal impairment. * **Hepatic Impairment:** Generally no specific dose adjustment, but monitor electrolytes. ## Contraindications * Hyperkalemia. * Conditions that predispose to hyperkalemia (e.g., severe renal impairment, untreated Addison's disease, acute dehydration, extensive tissue injury). * Certain medications (e.g., potassium-sparing diuretics, ACE inhibitors, ARBs, NSAIDs) may necessitate caution or dose adjustment. ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain, especially with oral formulations. * **Serious:** * **Hyperkalemia:** Signs include muscle weakness, paresthesias, cardiac arrhythmias (peaked T waves on ECG), cardiac arrest. * **Gastrointestinal:** Esophageal or gastric irritation/perforation (especially with undissolved or rapid administration of oral KCL tablets). * **Cardiovascular:** Hypotension, arrhythmias (especially with rapid IV infusion). * **Venous irritation/phlebitis** with IV administration. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride), ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), NSAIDs (e.g., ibuprofen):** Increased risk of hyperkalemia. * **Aldosterone antagonists:** Increased risk of hyperkalemia. * **Digoxin:** Hypokalemia enhances digoxin toxicity; hyperkalemia reduces it. * **Neuromuscular blocking agents:** Hyperkalemia can prolong neuromuscular blockade. * **Beta-blockers:** Can impair cellular uptake of potassium, increasing serum levels and risk of hyperkalemia. ## Monitoring * **Serum potassium levels:** Frequent monitoring is crucial, especially during IV therapy, with dose adjustments, or in patients with impaired renal function. * **Renal function:** Monitor BUN and creatinine. * **ECG:** Essential for patients receiving IV potassium, particularly rapid infusions, or those with pre-existing cardiac conditions or severe hypokalemia. Monitor for signs of hyperkalemia. * **Signs and symptoms of hypokalemia and hyperkalemia.** ## Clinical Pearls * Oral potassium chloride should be taken with food or milk to minimize gastrointestinal upset. * Dilute IV potassium chloride thoroughly in appropriate IV fluids before administration. Never administer IV potassium chloride undiluted as a bolus. * Always use an infusion pump for IV potassium administration. * In patients with severe hypokalemia or ECG changes, more aggressive IV correction may be required, but this carries higher risks and necessitates intensive monitoring. * The "Rule of Tens" for IV potassium: 10 mEq in 1 Liter, over 10 hours, not exceeding 10 mEq/hour, with serum potassium < 5.0 mEq/L. This is a conservative guideline for non-emergent correction. *** **Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and institutional protocols for definitive guidance, as drug information can change. Always verify dosing and safety parameters before administering any medication.